- Home
- LFUS vs AXSM Comparison
LFUS vs AXSM Comparison
Compare LFUS & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LFUS | AXSM |
|---|---|---|
| Founded | 1927 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electrical Products | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.3B | 12.0B |
| IPO Year | 1996 | 2015 |
Fundamental Metrics
Financial Performance| Metric | LFUS | AXSM |
|---|---|---|
| Price | $404.86 | $241.00 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 17 |
| Target Price | ★ $366.67 | $211.12 |
| AVG Volume (30 Days) | 320.1K | ★ 845.0K |
| Earning Date | 05-06-2026 | 05-04-2026 |
| Dividend Yield | ★ 0.77% | N/A |
| EPS Growth | N/A | ★ 38.56 |
| EPS | ★ 2.96 | N/A |
| Revenue | ★ $757,853,000.00 | N/A |
| Revenue This Year | $14.65 | $57.24 |
| Revenue Next Year | $6.98 | $55.88 |
| P/E Ratio | $140.26 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $227.73 | $96.09 |
| 52 Week High | $500.57 | $260.19 |
Technical Indicators
Market Signals| Indicator | LFUS | AXSM |
|---|---|---|
| Relative Strength Index (RSI) | 40.56 | 51.12 |
| Support Level | $385.67 | $236.44 |
| Resistance Level | $426.31 | $256.40 |
| Average True Range (ATR) | 14.57 | 9.57 |
| MACD | 0.47 | -0.26 |
| Stochastic Oscillator | 51.72 | 56.90 |
Price Performance
Historical ComparisonAbout LFUS Littelfuse Inc.
Littelfuse is a supplier of circuit protection products (such as fuses and relays) for the transportation, industrial, telecommunications, and consumer electronics end markets. Littelfuse also holds a minority power semiconductor business, primarily serving high-voltage industrial applications. Littelfuse sells globally across both distribution and direct channels, and organizes its business into the three segments of electronics, transportation, and industrial. Littelfuse is a serial acquirer of smaller, bolt-on adjacent firms.
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.